173.820 articles found

Explainable machine learning identifies predictors for postural instability and cognitive impairment in early Parkinson’s Disease

Sailer B, Roeben B, Kiefer C, Achauer L, Kemmner R, Wurster I, Lerche S, Bender B, Lindig T, Schulte C, Deuschle C, Erhardt C, Gasser T, Brockmann K, Kohlbacher O, the DIFUTURE consortium, Biergans S, Liepelt-Scarfone I.

· 2026-10-05

DOI: 10.64898/2026.09.30.26364120

Heterotypic Condensate Formation by Prion Proteins and Pro-Inflammatory S100A9

Veiveris D, Karalkevičiūtė V, Mikalauskaitė K, Šulskis D, Žiaunys M.

· 2026-10-05

DOI: 10.64898/2026.10.02.756240

The Somnogenesis System

Ndiaye MO.

· 2026-10-05

DOI: 10.14293/pr2199.004616.v1

Hyperexcitable primary somatosensory cortex in the MitoPark mouse model of Parkinson’s disease

Check source for author details

bioRxiv : the preprint server for biology · 2026-10-05

Neuromelanin-sensitive magnetic resonance imaging in the diagnosis and assessment of Parkinson's disease.

Zhang D, Yusufujiang A, Li H.

Front Neurol · 2026-10-05

DOI: 10.3389/fneur.2026.1908455PMID: 42898622

Comparative effects and dose-response relationships of exercise for finger dexterity and upper-limb function in Parkinson's disease: a Bayesian network and model-based dose-response meta-analysis.

Liu BY, Zhuang YX, Zhuang CK, Ruan H.

Front Neurol · 2026-10-05

DOI: 10.3389/fneur.2026.1964034PMID: 42903675

A 46-year-old man with progressive gait impairment and parkinsonism - when a simple diagnosis does not fit all symptoms.

Saccardin G, Monfrini E, Fontanesi D, Di Rauso G, Di Fonzo A, Rispoli V.

Neurol Sci · 2026-10-05

DOI: 10.1007/s10072-026-09461-yPMID: 42830340

Astaxanthin nanoemulsion attenuates paraquat-induced Parkinsonism via modulation of oxidative stress, neuroinflammation, and dopaminergic dysfunction in rats.

Aijaz M, Kumar A.

Xenobiotica · 2026-10-05

DOI: 10.1080/00498254.2026.2732969PMID: 42830532

Blood-brain barrier opening with focused ultrasound reduces neuromelanin in a non-human primate model.

Esteban-García N, Martín-Flórez C, Pineda-Pardo JA, López-Aguirre M, Carrillo M, Rodríguez-Rojas R, Trigo-Damas I, Lanciego JL, Vila M, Obeso JA, Blesa J.

Brain · 2026-10-05

DOI: 10.1093/brain/awag343PMID: 42831534

Poly(<i>N</i>-acryloyl L-tryptophan) nanoparticles: anti-inflammatory and neuroprotective effects.

Pareek D, Roy M, Patra S, Kudada AS, Gupta A, Das T, Singh TD, Das S, Mastai Y, Paik P.

J Mater Chem B · 2026-10-05

DOI: 10.1039/d6tb01760fPMID: 42831699

From danger to resolution: targeting purinergic signaling in CNS diseases.

Degryse C, Gupta K, Buée L, Burnouf T, Blum D, Chou ML.

Med Chem Res · 2026-10-05

DOI: 10.1007/s00044-026-03583-wPMID: 42831935

Anti-osteoporosis medications in persons with and without Parkinson disease in Finland.

Leung MTY, Lamidi ML, Tiihonen M, Hartikainen S, Bell JS, Turner JP, Tolppanen AM.

Arch Osteoporos · 2026-10-05

DOI: 10.1007/s11657-026-01780-zPMID: 42831953